Supplement: Crash Course with Rheumatoid Arthritis

Crash Course with Rheumatoid Arthritis By Juhi Yajnik © Courtesy of the Daily Press In 1987, Beverly Williams began a battle with rheumatoid arthritis. Williams was a 22-year-old newspaper reporter, fresh out of Virginia Tech, when her hands started to hurt. Her doctor sent her to a specialist who diagnosed rheumatoid arthritis. She took the news lightly. "But if I knew then, what I know now," she says

Written byJuhi Yajnik
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In 1987, Beverly Williams began a battle with rheumatoid arthritis. Williams was a 22-year-old newspaper reporter, fresh out of Virginia Tech, when her hands started to hurt. Her doctor sent her to a specialist who diagnosed rheumatoid arthritis. She took the news lightly. "But if I knew then, what I know now," she says, "I would have been devastated."

Over the years, her knees, hips, and shoulders started popping. One by one, Williams had them replaced with artificial joints. "I'm half me, half titanium," she laughs.

Despite all the pain and so many surgeries, Williams says she struggled the most with one challenge: giving up her independence. "It was a long time before I would ask for help," she says, "Now I don't hesitate for one second." She often asks male friends to help her with chores around the house. And at her request, the newspaper where she works replaced ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies